샘플 요청 목록

 카트 문의
시장보고서
상품코드
1514101

세계의 창상관리용 생물학적 제제 시장

Wound Care Biologics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 93 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 창상관리용 생물학적 제제 시장은 2030년까지 50억 달러에 달할 전망

2023년에 26억 달러로 평가된 세계의 창상관리용 생물학적 제제 시장은 분석 기간 2023년부터 2030년까지 CAGR 9.6%로 성장할 전망이며, 2030년에는 50억 달러에 달할 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 생물학적 피부 대체물은 CAGR 10.1%로 성장을 지속하고, 분석 기간 종료 시 31억 달러에 달할 것으로 예상됩니다. 외용제 부문의 성장률은 분석 기간 동안 CAGR 8.7%로 추정됩니다.

미국 시장은 6억 8,450만 달러로 추정, 중국은 CAGR 13.9%로 성장 예측

미국의 창상관리용 생물학적 제제 시장은 2023년 6억 8,450만 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 13억 달러 규모에 이를 것으로 예측되며 분석 기간 2023년부터 2030년까지 CAGR은 13.9%로 전망됩니다. 다른 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 5.1%와 8.6%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 약 6.1%로 성장할 것으로 예측됩니다.

세계의 창상관리용 생물학적 제제 시장-주요 동향 및 촉진요인 정리

의료 치료의 진화에서 창상관리용 생물학적 제제는 중요한 진보의 상징이며 치유 과정을 강화하기 위해 천연 및 합성 생체 재료의 혼합을 도입하고 있습니다. 상처 치료용 생물학적 제제는 성장 인자, 피부 대체물, 조직 기반 제품 등 생물학적 유래 물질을 사용하여 상처 치유를 촉진하는 것을 의미합니다. 이러한 생물학적 제제는 주로 당뇨병성 궤양, 열상, 심한 열상과 같은 전통적인 방법으로 치유되지 않는 복잡한 상처의 치료에 사용됩니다. 상처 치료용 생물학적 제제는 생물학적 물질의 자연 치유력을 이용하여 조직 재생을 촉진하고 회복 과정을 가속화합니다. 상처 치유는 세포 및 세포외 성분, 성장 인자, 매트릭스 금속 프로테아제의 고도의 상호작용에 의해 촉진되지만, 만성 상처에서는 이러한 상호작용이 손상되는 경우가 많습니다. 상처 치료 생명 공학은 생물학적 활성 치료를 상처 부위에 도입함으로써 이러한 결핍을 해결하는 것을 목표로 합니다. 그 중에서도 가장 유망한 것은 세포 기반의 치료법으로, 각질세포, 섬유아세포, 지방 유래 간질 세포 등의 줄기 세포의 재생 능력을 이용하고 있습니다. 이들은 상처층의 치유 수용성을 높이기 위해 자가 또는 동종 이식편으로 적용됩니다.

피부 보충제는 치유되지 않는 상처를 관리하는 데 중요한 역할을 하며, 일시적 또는 영구적인 해결책으로 제공되며 무세포 및 세포성 제품으로 분류됩니다. 후자는 살아있는 세포를 매트릭스에 통합하여 창상 폐쇄를 더 빠르고 효과적으로 만듭니다. 또한, 재조합 인간 혈소판 유래 성장 인자-BB(rhPDGF-BB)와 같은 외인성 성장 인자의 적용은 수리 과정을 자극하는 데 도움이 되지만, 성공은 상처층 상태에 크게 의존합니다. 또한, 피부의 세포 외 매트릭스를 모방 한 바이오 인공 비계가 개발되어 보다 정교한 상처 치료 접근법으로의 전환이 강조되었습니다. 콜라겐과 히알루론산과 같은 생물학적 성분을 포함한 이러한 스캐폴드는 치유를 지원할 뿐만 아니라 적극적으로 촉진하기 때문에 기존의 상처 드레싱과는 별개입니다. 창상관리용 생물학적 제제 시장의 최근 동향은 맞춤형 의료 및 비용 효과적인 치료 옵션에 대한 관심 증가를 반영합니다. 생물학적 물질을 환자 스스로가 아닌 기증자로부터 조달하는 동종요법으로의 전환이 현저하며, 이는 비용을 절감하고 치료 프로토콜을 단순화할 수 있습니다. 또한, 생물학적 제제를 이용한 치료에 대한 규제 당국의 지원도 확대되고 있으며, FDA 등의 기관으로부터 많은 제품이 패스트 트랙 지정이나 승인을 받고 있습니다.

세계 당뇨병 이환율 증가와 이에 따른 당뇨병성 궤양 증가로 효과적인 상처 치유 솔루션에 대한 수요가 계속 증가하고 있습니다. 당뇨병 환자는 종종 치유 능력이 떨어지기 때문에 생물학적 제제는 만성 상처 관리 및 합병증 예방에 중요한 역할을 합니다. 생명 공학의 진보는 치유 기간을 크게 단축하고 환자의 결과를 개선하는 보다 효과적이고 효율적인 생물학적 제제로 치료법을 개발할 수 있게 했습니다. 이러한 진보에는 성장 인자 기술, 유전자 조작에 의한 대용 피부, 배양 상피 자가 이식 등의 기술 혁신이 포함됩니다. 또한, 상처 치유를 해치는 만성 질환에 걸리기 쉬운 세계의 고령화에 의해 생물학적 치료에 대한 수요가 더욱 높아지고 있습니다.

조사 대상 기업 예(주목 42사)

  • Acell
  • Anika Therapeutics
  • Integra Lifesciences
  • Kerecis
  • Marine Polymer Technologies
  • Mimedx Group
  • Molnlycke Health Care AB(Investor AB)
  • Organogenesis
  • Osiris Therapeutics
  • Smith & Nephew

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향 및 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

AJY 24.07.24

Global Wound Care Biologics Market to Reach US$5.0 Billion by 2030

The global market for Wound Care Biologics estimated at US$2.6 Billion in the year 2023, is expected to reach US$5.0 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2023-2030. Biologic Skin Substitutes, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$3.1 Billion by the end of the analysis period. Growth in the Topical Agents segment is estimated at 8.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$684.5 Million While China is Forecast to Grow at 13.9% CAGR

The Wound Care Biologics market in the U.S. is estimated at US$684.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 13.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Wound Care Biologics Market - Key Trends and Drivers Summarized

In the evolving landscape of medical treatments, wound care biologics represent a significant advancement, introducing a blend of natural and synthetic biomaterials to enhance the healing process. Wound care biologics refer to the use of biologically derived materials, such as growth factors, skin substitutes, and tissue-based products, to facilitate the healing of wounds. These biologics are primarily used to treat complex wounds that do not heal easily through traditional methods, including diabetic ulcers, burns, and severe lacerations. By harnessing the natural healing capabilities of biological materials, wound care biologics promote tissue regeneration and accelerate the recovery process, making them an essential component of advanced wound management strategies. Wound healing is facilitated by a sophisticated interplay of cellular and extracellular components, growth factors, and matrix metalloproteinases, which are often compromised in chronic wounds. Wound care biotechnology aims to address these deficits by introducing biologically active treatments to the wound site. Among the most promising are cell-based therapies, which utilize the regenerative capabilities of stem cells such as keratinocytes, fibroblasts, and adipose-derived stromal cells. These are applied as either autologous or allogeneic grafts to enhance the wound bed's receptiveness to healing.

Skin substitutes play a crucial role in managing non-healing wounds, offered as either temporary or permanent solutions and are categorized into acellular and cellular products. The latter involves living cells integrated within a matrix, aiding in faster and more effective wound closure. Moreover, the application of exogenous growth factors such as recombinant human platelet-derived growth factor-BB (rhPDGF-BB) has become instrumental in stimulating repair processes, though their success largely depends on the wound bed's condition. Additionally, the development of bioartificial scaffolds that mimic the skin's extracellular matrix highlights the shift towards more sophisticated wound care approaches. These scaffolds, incorporating biological components such as collagen and hyaluronic acid, not only support but actively promote healing, distinguishing them from traditional wound dressings.Recent trends in the wound care biologics market reflect a growing focus on personalized medicine and cost-effective treatment options. There is a notable shift towards allogeneic therapies, where biologic materials are sourced from donors rather than from the patients themselves, which can reduce costs and simplify treatment protocols. Moreover, regulatory support for biologic-based therapies is expanding, with numerous products receiving fast-track designations and approvals from bodies such as the FDA.

Global increase in the prevalence of diabetes and the corresponding rise in diabetic ulcers  continues to fuel the demand for effective wound healing solutions. As diabetic patients often experience reduced healing capabilities, biologics play a crucial role in managing chronic wounds and preventing complications. Advancements in biotechnology have enabled the development of more effective and efficient biologic treatments that can significantly reduce healing times and improve patient outcomes. These advancements include innovations in growth factor technology, genetically engineered skin substitutes, and cultured epithelial autografts. Additionally, the aging global population, which is more susceptible to chronic conditions that impair wound healing, further increases the demand for biologic treatments.

Select Competitors (Total 42 Featured) -

  • Acell
  • Anika Therapeutics
  • Integra Lifesciences
  • Kerecis
  • Marine Polymer Technologies
  • Mimedx Group
  • Molnlycke Health Care AB (Investor AB)
  • Organogenesis
  • Osiris Therapeutics
  • Smith & Nephew

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Wound Care Biologics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Wounds and Diabetes-related Ulcers
    • Increasing Demand for Advanced Biological Wound Care Solutions
    • Technological Advancements in Biologic Wound Care Products
    • Growth in Surgical Procedures and Trauma Cases
    • Emergence of Stem Cell-based and Regenerative Therapies
    • Increasing Focus on Infection Control and Antimicrobial Biologics
    • Increasing Focus on Personalized and Targeted Wound Care Solutions
    • Role of Wound Care Biologics in Reducing Healing Time and Improving Outcomes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Wound Care Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Wound Care Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Wound Care Biologics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Biologic Skin Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Biologic Skin Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Biologic Skin Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Topical Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Topical Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Topical Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Surgical & Traumatic Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Surgical & Traumatic Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Surgical & Traumatic Wounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Burns by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Burns by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Burns by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for ASCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for ASCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for ASCs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Burn Centers & Wound Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Burn Centers & Wound Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Burn Centers & Wound Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Wound Care Biologics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • JAPAN
    • Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • CHINA
    • Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • EUROPE
    • Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Wound Care Biologics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Wound Care Biologics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Wound Care Biologics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • FRANCE
    • Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • GERMANY
    • Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Wound Care Biologics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Wound Care Biologics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Wound Care Biologics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • INDIA
    • Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Wound Care Biologics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Wound Care Biologics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Wound Care Biologics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Wound Care Biologics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Wound Care Biologics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Wound Care Biologics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
  • AFRICA
    • Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제